Применение богатой тромбоцитами плазмы в лечении дерматозов (обзор)

Литература:
1. Аминова 3.M., Емелин А.Л., Овечкина M.B., Калянова Е.В. Применение богатой тромбоцитами плазмы в ортопедии. Технология PlasmoliftingTM. Процедура Orthoplasma: метод, пособие для врачей. М., 2012; 149 с.
2. Безуглов Э. H., Ачкасов E.E., Усманова Э.М. и др. Применение тромбоци-тарных факторов роста при лечении повреждений латеральных связок голеностопного сустава у футболистов. Спортивная медицина: наука и практика 2013; (1): 31-5.
3. Войно-Ясенецкий В.Ф. Очерки гнойной хирургии. М.: Бином, 2006; 720 с
. 4. Брехов В. Л. Хирургическое лечение больных с дефектами костной и хрящевой тканей с применением богатой тромбоцитами аутоплазмы: дис. ... канд. мед. наук. Курск, 2007; 113 с.
5. Urist MR. Bone morphogenetic protein. J Dent Res 1972; 50: 1392.
6. Tyapongsak P, O'Brien D, Monteiro CB, et al. Autologius fibrin adhesive in mandibular reconstruction with participate cancellers bone and marrow. J Oral Maxillofacial Surg 1994; 52: 161-6.
7. Kasemkijwattana C, Menetrey J, Bosch P, et al. Use of growth factors to improve muscle healing after strain injury. Clin Orthop Relat Res 2000; 370: 272-85.
8. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003; 33: 381-94.
9. NagumoA, Yasuda K, Numazaki H,etal. Effects of separate application of three growth factors (TGF-beta1, EGF, and PDGF-BB) on mechanical properties of the in situ frozenthawed anterior cruciate ligament. Clin Biomech 2005; 20: 283-90.
10. Pujol JP, Chadjichristos C, Legendre F, et al. lnterleukin-1 and transforming growth factor-beta-1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 2008; 49: 293-7.
11. Foster ТЕ, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009; 37: 2259-72.
12. Sanchez M, Anitua E, Azofra J, et al. Intraarticular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008; 26: 910-3.
13. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surgery 2004; 62: 489-96.
14. De Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 2010; 13 (303): 144-9.
15. Sampson S, Gerhardt M, Mandelbaum B. Platelet-rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008; 1: 165-74.
16. Ачкасов E.E., Безуглов Э.Н., Ульянов А. А. и др. Применение аутоплазмы, обогащенной тромбоцитами, в клинической практике. Биомедицина 2013; 1 (4): 46-59.
17. Marx R. Platelet-rich plasma: evidence to support its use. Oral Maxillofac Surg 2004; 62 (4): 489-96.
18. Cheena L, Vivek M. Platelet-Rich Plasma in Dermatology. JK Science 2014; 16 (4): 147-50.
19. Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regenerative Medicine 2013; 8 (5): 645-58.
20. Whitman D, Berry R, Green D. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. Oral Maxillofac Surg 1997; (55): 1294-9.
21. Marx R, Carlson E, Eichstaedt R, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; (85): 638-46.
22. Li X, Zhou X, Zeng S, et al. Effects of intramyocardial injection of platelet-rich plasma on the healing process after myocardial infarction. Coron Artery Dis 19 (5); 363-70.
23. Bosch G, Moleman M, Barneveld A, et al. The effects of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports 2011; 21 (4): 554-61.
24. Lopez-Plandolit S, Morales M, Freire V, et al. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 2010; 29 (8): 843-8.
25. Gentile P, Pasquali C, Bocchini C, et al. Brest reconstruction with autologous fat graft mix with platelet-rich plasma. Surg Innov 2012; 20 (4): 370-6.
26. Sommeling C, Heyneman A, et al. The use of platelet-rich plasma in plastic surgery: a systematic review. Plastic Reconstructive Aestetic Surgery 2012; 66 (3): 301 -11.
27. Na J, Choi J, Choi H, et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg 2011; 37 (4): 463-8.
28. Carter CA, Jolly DG, Worden CE, et al. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003; 74 (3): 244-55.
29. Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 2006; 118: 1458-67.
30. Greco J, Brandt R. The effects of autologous platelet-rich plasma and various growth factors on non-transplanted miniaturized hair. Hair Transplant Forum International 2009; 49-50.
31. Gkini MA, Alexandros-Efstratios K, Dimitris R, Konstantinos K. Platelet-rich plasma as a potential treatment for noncicatricial alopecias. Int J Trichology 2015; 7 (2): 54-63.
32. Пахомова E.E., Смирнова И.О. Молекулярно-биологические и клинические аспекты применения плазмы, обогащенной тромбоцитами, в лечении андрогенетической алопеции. Клиническая дерматология и венерология 2017; 16 (6): 16-22.
33. Kozlowska U, Blume-Peytavi U, Kodelja V, et al. Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res 1998; 290 (12): 661-8.
34. Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001; 107 (4): 409-17.
35. Cervelli V, Garcovich S, Bielli A, et al. The effect of autologous activated platelet-rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014.
36. Li ZJ, Choi H-l, Choi D-K, et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012; 38 (7): 1040-6.
37. Kwack M, Kim M, Kim J, Sung J. Dickkopf 1 promotes regression of hair follicles. J Invest Dermatol 2012; 132 (6): 1554-60.
38. Sohn КС, Shi G, Jang S, et al. Pitx2, a beta-catenin-regulated transcription factor, regulates the differentiation of outer root sheath cells cultured in vitro. J Dermatol Sci 2009; 54 (1): 6—11.
39. Takakura N, Yoshida H, Kunisada T, et al. Involvement of platelet-derived growth factor receptor-alpha in hair canal formation. J Invest Dermatol 1996; 107 (5): 770-7.
40. Rinaldi F, Sorbellini E, Bezzola P. The role of up-stimulation of growth factors in hair transplantation: improve the revascularization of transplanted hair growth mediated by angiogenesis. Hair Transplant Forum Int 2007; 17 (4): 125-7.
41. Поляева Т.О., Утц С.Р. Применение обогащенной тромбоцитами плазмы в дерматокосметологии (обзор). Саратовский научно-медицинский журнал 2016; 12 (3): 518-20.
42. Dhurat R, Sukesh М. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg 2014; 7 (4): 189-97.
43. Graziani F, Ivanovski S, Cei S, et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006; 17 (2): 212-9.
44. Kakudo N, et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008; 122 (5): 1352-60.
45. Tuomi H, Best TM. The inflammatory response: friend or enemy to muscle tissue? Br J Sports Med 2003; 37 (4): 284-6.
46. Anitua E, Alonso R, Girbau C, et al. Antibacterial effect of plasma rich in growth factors (PRGF-Endoret) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol 2012; 37 (6): 652-7.
47. Кудревич Ю.В., Зиганшин О. P. Применение техники «Плазмолифтинг» в лечении некоторых хронических дерматозов. В сб.: Актуальные вопросы дерматовенерологии и косметологии: материалы Юбилейной научно-практической конференции дерматовенерологов и косметологов, посвященной 75-летию дерматовенерологической службы Челябинской области. Челябинск, 2012; с. 61-2.
48. Deglesne PA, Arroyo R, Ranneva Е, et al. In vitro study of RRS HA injectable mesotherapy/biorevitalization product on human skin fibroblasts and its clinical utilization. Clin Cosmet Investig Dermatol 2016; 9: 41-53.
49. Zhu JT, Xuan M, Zhang YN, et al. The efficacy of autologous platelet-rich plasma combined with erbium fractional laser therapy for facial acnes cars or acne. Mol Med Rep 2013; 8(1): 233-7.
50. Herber OR, Schnepp W, Rieger MA. A systematic review on the impact of leg ulceration on patients quality of life. Health Qual Life Outcomes 2007; (5): 44.